Drug Type Synthetic peptide |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism TGF-β inhibitors(Transforming growth factor beta inhibitors), THBS1 antagonists(Thrombospondin 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H22N4O3 |
InChIKeyXBCYIRCOIWJBTN-QMMMGPOBSA-N |
CAS Registry2307429-54-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | United States | 07 May 2020 | |
Neoplasms | Preclinical | United States | 07 May 2020 |